Key facts
- This page summarizes Susan E. Knight's Form 4 filing for SURMODICS INC (SRDX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 02 Mar 2022, 15:02.
Susan E. Knight - 28 Feb 2022 Form 4 Insider Report for SURMODICS INC (SRDX)
- Reporting relationship
- Director
- Issuer ticker
- SRDX
- Reported as of
- 28 Feb 2022
- Net transaction value
- -$108,226
- SEC form
- 4
- Accepted by SEC
- 02 Mar 2022, 15:02:18 UTC
- Prior SEC filing
- 14 Feb 2022
- Next SEC filing
- 13 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Manders, on behalf of Susan E. Knight
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Susan E. Knight filed Form 4 for SURMODICS INC (SRDX) on 02 Mar 2022.
Change
- Previous filing in this sequence was filed on 14 Feb 2022.
- Current net transaction value: -$108,226.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SRDX
transaction
Common Stock
Options Exercise
- Transaction value
- $88,106
- Shares
- +4,366
- Change %
- +14%
- Price
- $20.18
- Shares after
- 34,562
- Date
- 28 Feb 2022
- Ownership
- Direct
SRDX
transaction
Common Stock
Sale
- Transaction value
- $196,332
- Shares
- -4,366
- Change %
- -13%
- Price
- $44.97
- Shares after
- 30,196
- Date
- 28 Feb 2022
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SRDX
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -4,366
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 28 Feb 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,366
- Exercise price
- $20.18
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Reflects the weighted average price of 4,366 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 28, 2022 with sale prices ranging from $44.96 to $45.08 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F2
The amount beneficially owned includes 13,203 restricted stock units (RSUs) that vest on service-based vesting dates that will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
Footnote F3
Fully vested.